PuSH - Publikationsserver des Helmholtz Zentrums München

Export: TXT Text RIS Endnote (RIS) BIB BibTeX
Palma, M.* ; Chaufan, M.* ; Breuer, C.B.* ; Müller, S.* ; Sabatier, M.* ; Fraser, C.S.* ; Szylo, K.J.* ; Yavari, M.* ; Carmona, A.* ; Kaur, M.* ; Melo, L.M.N.* ; Cansiz, F.* ; Monge-Lorenzo, J.* ; Flores, M.A.E.* ; Mishima, E. ; Nakamura, T. ; Proneth, B. ; Labrado, M.* ; Liang, Y.* ; Cayting, N.* ; Zheng, L.* ; Cañeque, T.* ; Colombeau, L.* ; Wahida, A. ; Friedmann Angeli, J.P.* ; Tasdogan, A.* ; Hui, S.T.* ; Rodriguez, R.* ; Conrad, M. ; Reticker-Flynn, N.E.* ; Ubellacker, J.M.*

Lymph node environment drives FSP1 targetability in metastasizing melanoma.

Nature, DOI: 10.1038/s41586-025-09709-1 (2025)
Verlagsversion Forschungsdaten DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
Ferroptosis has emerged as an actionable target to eliminate therapy-resistant and metastatic cancers1. However, which ferroptosis surveillance systems may offer a therapeutic window to leverage redox maladaptation in cancer remains unclear. In melanoma, glutathione peroxidase 4 (GPX4) impedes ferroptosis during haematogenous metastasis, but is dispensable during lymphatic metastasis2. Here, using a metastatic mouse melanoma model selected for lymph node metastasis, we show that lymph-node-derived metastatic cells exhibit markedly diminished expression of glutamate-cysteine ligase (GCLC) and reduced glutathione (GSH) levels relative to their parental counterparts. This metabolic shift occurs within the hypoxic lymphatic niche. Under comparable low-oxygen conditions, GPX4 undergoes ubiquitination and proteasomal degradation. In response, lymph node metastatic cells acquire increased reliance on ferroptosis suppressor protein 1 (FSP1), which is localized with perinuclear lysosomes. These findings reveal that the reduced reliance on the GPX4 axis enables melanoma cells to shift toward FSP1 dependency. Notably, intratumoural monotherapy with selective FSP1 inhibitors (viFSP1 and FSEN1) effectively suppresses melanoma growth in lymph nodes, but not in subcutaneous tumours, emphasizing a microenvironment-specific dependency on FSP1. Thus, targeting FSP1 in the lymph nodes holds strong potential for blocking melanoma progression.
Impact Factor
Scopus SNIP
Altmetric
48.500
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0028-0836
e-ISSN 1476-4687
Zeitschrift Nature
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Metabolism and Cell Death (MCD)
POF Topic(s) 30203 - Molecular Targets and Therapies
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-506900-001
DOI 10.1038/s41586-025-09709-1
PubMed ID 41193799
Erfassungsdatum 2025-11-07
[➜Korrektur melden]